Published in Health Business Week, April 20th, 2007
Lux Biosciences expects to enroll a total of more than 400 patients across two pivotal protocols. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.